Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
The European Respiratory Journal|June 1, 1997
Genetic risk factors for chronic obstructive pulmonary diseaseA J Sandford, T D Weir, P D ParéDisease Markers|April 29, 1998
Alpha 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary diseaseA J Sandford, T Chagani, T D Weir, et al.American Journal of Respiratory Cell and Molecular Biology|January 28, 1999
Z and S mutations of the alpha1-antitrypsin gene and the risk of chronic obstructive pulmonary diseaseA J Sandford, T D Weir, J J Spinelli, et al.Journal of Medical Genetics|November 14, 1997
Mutation in the 3' region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary diseaseA J Sandford, J J Spinelli, T D Weir, et al.American Journal of Respiratory and Critical Care Medicine|August 10, 2000
The effect of age and duration of disease on airway structure in fatal asthmaT R Bai, J Cooper, T Koelmeyer, et al.American Journal of Respiratory Cell and Molecular Biology|April 1, 1999
Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF releaseD A Knight, C P Lydell, D Zhou, et al.American Journal of Respiratory and Critical Care Medicine|February 17, 2001
Susceptibility genes for rapid decline of lung function in the lung health studyA J Sandford, T Chagani, T D Weir, et al.American Journal of Respiratory and Critical Care Medicine|March 28, 1998
Vitamin D binding protein variants and the risk of COPDD Schellenberg, P D Paré, T D Weir, et al.Thorax|July 30, 2003
Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokersL Joos, T D Weir, J E Connett, et al.Thorax|October 20, 2001
Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokersL Joos, L McIntyre, J Ruan, et al.Pageof 2